DENVER, Nov. 1, 2022 /CNW/ – Healthcare Technology in Action Schwazz(OTCQX: SHWZ) (NEO: SHWZ) (“Schwazz” or the “Company”), happy to announce that Justin DyeChairman & CEO; Nirup Krishnamurthy, President; and Nancy HuberCFO will host the Schwazze Third Quarter conference call on November 9, 2022, c 5:00 pm ET. (CNW Group/Medicine Man Technologies, Inc.) (CNW Group/Medicine Man Technologies, Inc.)

Investors and stakeholders may participate in the conference call by dialing 416-764-8650 or by calling North America toll-free at 1-888-664-6383 or listen online from the Company’s website at The webcast will be available on the Company’s website and replay until November 16, 2022and can be reached by calling 1-888-390-0541 / 997573 #.

After their prepared remarks, Chief Executive Officer, Justin Dye; President, Nirup Krishnamurthy; and the Chief Financial Officer, Nancy Huber will answer investment questions. Investors may submit questions prior to or during the conference call via the weblink: This webcast is posted on the web of the Company and will be stored on the website. All of the Company’s SEC filings are also available on the Company’s website at

Upcoming events:
MJ BizCon – Las Vegas, November 16-18, 2022
Justin DyeChairman & CEO and Nancy HuberCFO will attend MJ BizCon Las Vegas November 16-18 at the Las Vegas Convention Center. The Authority will also participate in meetings of business people in this event (Booth #3007). For more information or to arrange a meeting please get in touch Joanne JobinIRO at

Grade 11th Annual Research Conference – New York CityDecember 1, 2022
Justin DyeChairman & CEO and Nancy HuberCFO will attend the afternoon of the 11thth Annual Research Conference at the Sports Club of New York, 180 Central Park South in Manhattan. Management will attend individual investor meetings throughout the meeting. For more information, please contact your appropriate representative.

About Schwazze
Schwazze (OTCQX:SHWZ, NEO:SHWZ) is building a regional integrated services company with assets in Colorado and New Mexico and will continue to take its approach to other states to develop a unique regional leadership position. Schwazze is the parent company of a portfolio of well-known cannabis businesses and brands that see seeds for sale. The Company is committed to unlocking the full potential of the cannabis plant to improve the human condition. Schwazze is anchored in a high performance culture that combines customer-centric thinking with data science to measure, measure, and model options and outcomes. The Company’s leadership team has deep expertise in marketing, sales, and product development in Fortune 500 companies as well as in the cannabis sector. Schwazze is passionate about making a difference in our communities, promoting diversity and inclusion, and doing our part to be inclusive. Best price. Medicine Man Technologies, Inc. was the original trade name of Schwazze. The company continues to be known as Medicine Man Technologies, Inc.

The Schwazze gets its name from the decoration of a cannabis plant to improve the plant’s structure and improve health.

Forward-Looking Information
This press release contains “forward-looking statements.” Such statements may be preceded by the words “plan,” “will,” “may,” “forecast,” or similar words. Forward-looking statements are not guarantees of future events or performance, are based on certain assumptions, and are subject to a number of contingencies and uncertainties, many of which cannot be controlled by the Company and cannot be predicted or estimated. Accordingly, actual events and results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) our inability to manufacture our products and product substitutes on a commercial scale; ourselves or in collaboration with other parties; (ii) difficulties in obtaining financing on reasonable commercial terms; (iii) changes in the scope and nature of our competition; (iv) loss of one or more key managers or scientists; (v) difficulties in securing legal approval to market our products and product candidates; (vi) our ability to effectively execute our internal growth strategy Colorado and out of state, (vii) our ability to complete the acquisition described in this press release or to approve and execute future acquisitions consistent with our strategy, (viii) our ability to integrate with the business success acquired and realized with it, (ix) the ongoing COVID-19 pandemic, * the timing and scope of government stimulus programs, (xi) uncertainty about the application of federal, state and local laws to our business, and any changes in such laws, and * the inability to satisfy the closing. The conditions for the private search are described in this press release. Detailed information about the Company and the risks that may affect the performance of the information provided in the Company’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report in the Form 10-K and its Quarterly. Report on Form 10-Q. Investors and securities investors are encouraged to read these documents for free on the SEC’s website at The Company undertakes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or anything else unless required by law.



View pre-release downloads:–participation-in-upcoming-conferences–events-301664013 .html

SOURCE Medicine Man Technologies, Inc.



View the first release downloads:

Source link